Myfortic (Mycophenolic acid) Customer Reviews


Rx Prescription Required    RxFormulation : Delayed Release Tablet

StrengthQuantity & PriceBuy Now
Buy Now
Buy Now
norton image
Generic alternative for Myfortic

Mycophenolic acid

Rx Prescription Required    RxFormulation : Tablet

StrengthQuantity & PriceBuy Now
Buy Now
norton image

We are Certified



Mycophenolate is employed concomitantly with other medications to mitigate the risk of immune system rejection of transplanted organs among adults and children aged 3 months and above who have undergone kidney, heart, or liver transplantation. Belonging to the category of immunosuppressive agents, mycophenolate functions by attenuating the immune system’s response, thereby averting its potential to target and repudiate the transplanted organ.

Uses and Dosage

Mycophenolate is available in several formulations including capsules, tablets, delayed-release tablets (which release the medication in the intestine), and a suspension (liquid) for oral administration. Typically, it is administered twice daily on an empty stomach, either one hour prior to or two hours after eating or drinking, unless otherwise directed by a medical professional.

Maintain a consistent schedule, aiming for approximately 12-hour intervals between doses. Adhere strictly to the prescribed regimen, avoiding any deviations in dosage frequency or quantity, in line with your doctor’s recommendations.

The delayed-release tablet variant is absorbed by the body differently from the suspension, tablet, and capsule formulations. These products are not interchangeable, and when receiving your prescription, ensure that the correct variant is provided.

Tablets, delayed-release tablets, and capsules should be swallowed whole, without splitting, chewing, or crushing. Capsules must not be opened, but if accidentally breached, contact with skin or eyes, as well as inhalation of the powder, should be avoided. In case of contact, the affected area should be thoroughly washed with soap and water; eyes should be rinsed with water.

The mycophenolate suspension should not be mixed with any other medications. Care should be exercised to prevent spills or splashes onto the skin. In case of skin contact, the area should be cleansed with soap and water. If the suspension comes into contact with the eyes, rinsing with plain water is recommended. Spilled liquids can be cleaned using wet paper towels.

Mycophenolate’s effectiveness in preventing organ transplant rejection is contingent upon continuous usage. Even if you feel well, adherence to the prescribed regimen is essential. Discontinuation of mycophenolate should only be considered after consulting your doctor.

Side Effects

Some side effects may occur that usually do not need medical attention:

  • constipation
  • nausea
  • vomiting
  • difficulty falling asleep or staying asleep
  • pain, especially in the back, muscles, or joints
  • headache
  • gas
  • prickling, tingling, or burning feeling on the skin
  • swelling of the hands, arms, feet, ankles, or lower legs
  • tremor

Inform your healthcare provider immediately if you experience any serious side effects:

  • sudden severe stomach pain, stomach pain that doesn’t go away, or diarrhea
  • difficulty breathing
  • chest pain
  • rash
  • itching
  • dizziness, fainting, pale skin, lack of energy, shortness of breath, or fast heartbeat
  • unusual bleeding or bruising; vomiting or spitting up blood or brown material that resembles coffee grounds; bloody or black, tarry stools; or blood in urine
  • fever, muscle or joint stiffness or pain


Prior to initiating the use of mycophenolate sodium, inform your healthcare provider or pharmacist about any known allergies to mycophenolate sodium, mycophenolic acid, mycophenolate mofetil, or any other allergens. This product might contain inactive components capable of triggering allergic reactions or other adverse effects.

Before commencing treatment with this medication, communicate your medical history to your doctor or pharmacist, particularly if you have a history of cancer, liver diseases such as hepatitis B or hepatitis C, ongoing or past infections such as herpes or shingles, gastrointestinal disorders like ulcers, or rare genetic disorders like Lesch-Nyhan or Kelley-Seegmiller syndromes.

This medication has the potential to induce dizziness or drowsiness. The simultaneous use of alcohol or marijuana may exacerbate these effects. Engaging in activities that demand alertness, such as driving or operating machinery, should be avoided until you can safely do so.

Mycophenolate can elevate the susceptibility to infections or exacerbate existing infections. Caution is advised around individuals who carry infections that can be easily transmitted, like chickenpox, COVID-19, measles, or the flu. In case of exposure to an infection or for additional information, consult your doctor.

Prior to undergoing immunizations or vaccinations, notify your healthcare professional about your use of mycophenolate sodium. Steer clear of contact with individuals who have recently received live vaccines, such as the nasal flu vaccine.

Exercise caution when handling sharp objects like razors or nail cutters to minimize the risk of cuts, bruises, or injuries. Activities involving contact sports should also be approached cautiously.

During the course of mycophenolate treatment and for six weeks after its cessation, refraining from blood donation is recommended. For male patients using mycophenolate, the recommendation is to abstain from sperm donation during treatment and for 90 days following its discontinuation.

Given the potential for this medication to be absorbed through the skin and lungs, which could pose a risk to an unborn baby, pregnant women or those considering pregnancy should not handle this medication or inhale dust from its tablets.

If you are pregnant or planning to conceive, inform your doctor. Pregnancy tests might be ordered before initiating treatment, approximately 8 to 10 days after treatment initiation, and during regular follow-up visits. Usage of mycophenolate during pregnancy could harm the fetus. Women of childbearing age should discuss reliable forms of contraception while using this medication and for six weeks after the last dose.

Men with female partners of childbearing age should also employ reliable birth control methods during treatment and for three months post-treatment discontinuation. In the event of pregnancy, promptly consult your doctor regarding the potential benefits and risks associated with this medication.

The passage of this drug into breast milk remains uncertain. Due to potential risks to the infant, breastfeeding while on this medication is not advised. Consult your doctor before making decisions regarding breastfeeding.

Form and Strength

Myfortic is available in the following forms and strengths:

  • Myfortic delayed-release tablet:

    • 180mg
    • 360mg
  • mycophenolic acid tablet:

    • 360mg


When is the best time to take Myfortic?

It is best to take this medicine on an empty stomach, either 1 hour before or 2 hours after meals, unless your doctor tells you otherwise.

How long should you take Myfortic?

You should continue to take Myfortic and your anti-rejection medications until your provider tells you to stop.



Additional information

Generic name:

Mycophenolic Acid, Mycophenolic acid


Delayed Release Tablet, Tablet


180mg, 360mg

Quantities Available:

100, 120

Can Drug Store has provided information from third parties intended to increase awareness and does not contain all the information about Myfortic (Mycophenolic acid). Talk to your doctor or a qualified medical practitioner for medical attention, advice, or if you have any concerns about Myfortic (Mycophenolic acid).